Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,139,295
-$1,462,240 QoQ
Shares Held
285,834
+1.4% QoQ
Ownership
0.587%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $211,400,940 across 22 Biotechnology names. URGN ranks #13 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
283,567 | $56,614,151 | |
| 2 | ASND |
Ascendis Pharma A/S
|
148,386 | $33,940,329 | |
| 3 | VRDN |
Viridian Therapeutics, Inc.\DE
|
898,611 | $17,576,831 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
617,489 | $13,745,305 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
147,037 | $13,583,278 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
770,711 | $11,144,481 | |
| 7 | TSHA |
Taysha Gene Therapies, Inc.
|
1,944,671 | $8,692,679 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
487,898 | $7,230,648 |
All Filings in URGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,139,295 | 285,834 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,601,535 | 281,876 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,169,902 | 259,143 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $3,943,873 | 287,874 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,829,048 | 255,791 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,811,930 | 264,031 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $3,453,091 | 271,897 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,221,365 | 72,787 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,056,090 | 70,406 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,048,380 | 69,892 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,053,271 | 75,180 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $787,500 | 76,087 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $676,414 | 73,205 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $646,897 | 72,931 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $619,265 | 74,431 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $904,642 | 110,457 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $940,592 | 107,990 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $963,924 | 101,359 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,510,553 | 149,260 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,689,796 | 241,637 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $5,586,961 | 286,805 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,838,995 | 102,053 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||